UCSF

Wells Joins UCSF as First Hind Professor

James Wells, PhD, a leader in the development of new technologies to aid drug discovery and protein engineering, joins UCSF as the first holder of the Harry Wm. and Diana V. Hind Distinguished Professorship in Pharmaceutical Sciences. Wells will hold joint faculty appointments in the Schools of Pharmacy and Medicine. Wells is a member of the National Academy of Sciences and co-founder of Sunesis, the South San Francisco pharmaceutical company. "Jim is a highly regarded and highly accomplished scientist," said Mary Anne Koda-Kimble, PharmD, dean of the UCSF School of Pharmacy. "We count ourselves lucky he chose UCSF as his next research home. He is the perfect first holder of the Hind professorship." • More information: Pioneer in Biotech Research and Drug Development Appointed to UCSF Faculty and Hinds Establish Pharmacy's First Distinguished Professorship.


About the School: The UCSF School of Pharmacy is a premier graduate-level academic organization dedicated to improving health through precise therapeutics. It succeeds through innovative research, by educating PharmD health professional and PhD science students, and by caring for the therapeutics needs of patients while exploring innovative new models of patient care. The School was founded in 1872 as the first pharmacy school in the American West. It is an integral part of UC San Francisco, a leading university dedicated to promoting health worldwide.